Neovasc to Report First Quarter Financial Results on May 12, 2022
April 29 2022 - 9:05AM
via NewMediaWire -- Neovasc Inc. (NASDAQ ,
TSX : NVCN), will report financial results for the
quarter ended March 31, 2022 on Thursday, May 12, 2022. Neovasc’s
President and Chief Executive Officer Fred Colen, and Chris Clark,
Chief Financial Officer, will host a conference call to review the
company’s results at 4:30 pm EDT on May 12, 2022.
Interested parties may access the conference call
by dialing (877) 407-9208 or (201) 493-6784 (International) and
reference Conference ID 13729200. Participants wishing to join the
call via webcast should use the link posted on the investor
relations section of the Neovasc website at
neovasc.com/investors/. A replay of the webcast will be
available approximately 30 minutes after the conclusion of the call
using the link on the Neovasc website.
About Neovasc Inc.
Neovasc is a specialty medical device company that
develops, manufactures, and markets products for the rapidly
growing cardiovascular marketplace. Its products include Reducer,
for the treatment of refractory angina, which is under clinical
investigation in the United States and has been commercially
available in Europe since 2015, and Tiara™ for the
transcatheter treatment of mitral valve disease, which is currently
under clinical investigation in the United States, Canada, Israel
and Europe. For more information, visit: www.neovasc.com.
Forward-Looking Statement
Disclaimer
Certain statements in this news release contain
forward-looking statements within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and applicable Canadian
securities laws that may not be based on historical fact. When used
herein, the words expect, anticipate, estimate, may, will, should,
intend, believe, and similar expressions, are intended to identify
forward-looking statements. Forward-looking statements may involve,
but are not limited to, the growing cardiovascular marketplace.
Forward-looking statements are based on estimates and assumptions
made by the Company in light of its experience and its perception
of historical trends, current conditions and expected future
developments, as well as other factors that the Company believes
are appropriate in the circumstances. Many factors could cause the
Company’s actual results, performance or achievements to differ
materially from those expressed or implied by the forward-looking
statements, including those described in the Risk Factors section
of the Company’s Annual Report on Form 20-F and in the Managements
Discussion and Analysis for the year ended December 31, 2021
(copies of which may be obtained at www.sedar.com or www.sec.gov ).
These factors should be considered carefully, and readers should
not place undue reliance on the Company’s forward-looking
statements. The Company has no intention and undertakes no
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Contacts
Investors
Mike CavanaughWestwicke/ICRPhone:
+1.617.877.9641Email: Mike.Cavanaugh@westwicke.com
Media
Sean LeousWestwicke/ICRPhone:
+1.646.866.4012Email: Sean.Leous@icrinc.com
Neovasc (TSX:NVCN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Neovasc (TSX:NVCN)
Historical Stock Chart
From Oct 2023 to Oct 2024